- Solid Tumors
- Pipeline Molecules
- Alliance Partners
Our mission is to provide healthcare professionals with unbiased clinical research information, easily.
Currently, you can access the following clinical trials being conducted worldwide:
Clinicaltrials.gov identifier NCT03932071
Recruitment Status Recruiting
First Posted April 30, 2019
Last update posted May 6, 2019
Zoledronic acid is an adjuvant treatment for primary osteosarcoma. Zoledronic acid has been widely used in the treatment of metastatic bone tumors. In addition to its inhibition of tumor osteoclasis, it also produces certain killing of tumor cells. effect. Foreign studies have shown that zoledronic acid also has a killing effect on osteosarcoma and has a certain inhibitory effect on distant metastasis. We hope that it can reduce tumor recurrence and lung metastasis through this study.
|Experimental: experimental group
Drug: Zoledronic Acid
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, , Learn About Clinical Studies.-->
- Patients with osteosarcoma who were diagnosed with initial pathology and pathology
were excluded from lung metastasis or other metastatic lesions by CT and total body
emission-computed tomography, and patients with standard chemotherapy were evaluated.
- Pulmonary metastasis, pregnancy or lactation, renal insufficiency (creatinine
clearance <70 ml/min/1.73 m2), liver dysfunction, obvious oral disease, and unsuitable for bisphosphonate treatment after evaluation, have been found. With diseases that still require hormone therapy, abnormal blood system, heart disease
Contact: Xiaobo Yan, Dr. +8613588153306 email@example.com
2nd Affiliated Hospital of Zhejiang University
Second Affiliated Hospital, School of Medicine, Zhejiang University
Principal Investigator: zhaoming Ye, Prof. 2nd Affiliated Hospital Of Zhejiang University